Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: Evidence for a threshold effect

Atherosclerosis

Volumn 135, Issue 2, 1997, Pages 257-262

  Pfohl, Martin ^a   Naoumova, Rossitza P ^b   Neuwirth, Clare ^b   Sussekov, Andrey ^b   Smykowski, J ^a   Rendell, Nigel B ^b   Taylor, Graham W ^b   Seif, F J ^a   Thompson, Gilbert R ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Lathosterol Simvastatin HMG CoA reductase inhibitor; Mevalonic acid

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; SIMVASTATIN;

ADULT; APHERESIS; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; ENZYME INHIBITION; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; MALE; MAXIMUM ALLOWABLE CONCENTRATION; PLASMA VOLUME; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADULT; BLOOD COMPONENT REMOVAL; CHOLESTEROL; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPOPROTEINS, LDL; MALE; MEVALONIC ACID; UP-REGULATION;

EID: 0031438512     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00173-1     Document Type: Article

References (27)

1. Dietschy JM, Turley SD, Spady DK Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res. 34:1993;1637-1659.
2. Pfohl M, Naoumova RP, Klass C, Knisel W, Jakober B, Risler R, Thompson GR Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor. J Lipid Res. 35:1994;1946-1955.
3. Reihner RD, Stahlberg S, Rudling M, Ewerth S, Björkhem I, Einarsson K, Angelin B Effects of pravastatin (SQ 31 000) on hepatic cholesterol metabolism in man. N Engl J Med. 323:1990;224-228.
4. Miettinen TA Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci. 8:1969;713-721.
5. Kempen HJM, Glatz JFC, Gevers Leuven JA, van de Voort HA, Katan MB Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res. 29:1988;1149-1155.
6. Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batwin H, Ahrens EH Jr. Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc Natl Acad Sci USA. 79:1982;3037-3041.
7. Parker TSet al. Plasma mevalonate as a measure of cholesterol biosynthesis in man. J Clin Invest. 74:1984;795-804.
8. De Cuyper I, Wolthers BG, van Doormal JJ, Wijnandts PN Determination of changes in serum lathosterol during treatment with simvastatin to evaluate the role of lathosterol as a parameter for whole body cholesterol synthesis. Clin Chim Acta. 219:1993;123-130.
9. Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR Plasma mevalonic acid, an index of cholesterol biosynthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis. 119:1996;203-213.
10. Yokoyama S, Hayashi R, Satani M, Yamamoto A Selective removal of low-density-lipoprotein (LDL) by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis. 5:1985;613-622.
11. Lopes-Virella MF, Stone P, Ellis S, Colwell SA Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem. 23:1977;882-884.
12. Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
13. Weisweiler P, Schwandt P, Friedl C Determination of human apolipoprotein A1, B and E by laser nephelometry. J Clin Chem Biochem. 22:1984;113-118.
14. Scoppola A, Maher VMG, Thompson GR, Rendell NB, Taylor GW Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J Lipid Res. 32:1991;1057-1060.
15. Goldstein JL, Brown MS Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
16. Yoshida T, Honda A, Tanaka N, Matsuzaki Y, He B, Osuga T, Kobayashi N, Ozawa K, Miyazaki H Simultaneous determination of mevalonate and 7-hydroxy-cholesterol in human plasma by gas chromatography-mass spectrometry as indices of cholesterol and bile acid biosynthesis. J Chromatograph. 613:1993;185-193.
17. Björkhem I, Miettinen TA, Reihner E, Ewerth S, Angelin B, Einarsson K Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res. 28:1987;1137-1143.
18. McNamara DJ, Ahrens EH, Parker TS Role of the kidney in the metabolism of plasma mevalonate. Studies in humans and rhesus monkeys. J Clin Invest. 76:1985;31-39.
19. Duane WC Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol. J Lipid Res. 36:1995;343-348.
20. Gordon BR, Saal SD Advances in LDL apheresis for the treatment of severe hypercholesterolemia. Curr Op Lipidol. 5:1994;69-73.
21. Thompson GR, Myant NB Low density lipoprotein turnover in familial hypercholesterolaemia after plasma exchange. Atherosclerosis. 23:1976;371-377.
22. Apstein CS, Zilversmit DB, Lees RS, George PK Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia. Atherosclerosis. 31:1978;105-115.
23. Eriksson M, Berglund L, Gabrielsson J, Lantz B, Angelin B Non-steady-state kinetics of low density lipoproteins in man: studies after plasma exchange in healthy subjects and patients with familial hypercholesterolaemia. Eur J Clin Invest. 23:1993;746-752.
24. Kellogg RM, Hester JP Kinetics modelling of plasma exchange: intra- and post-plasma exchange. J Clin Apheresis. 4:1988;183-187.
25. Thompson GR, Naoumova RP, Watts GF Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res. 37:1996;439-447.
26. Masucci-Magoulas L, Plump A, Jiang XC, Walsh A, Breslow JL, Tall AR Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. J Clin Invest. 97:1996;154-161.
27. Naoumova RP, Marais D, Firth JC, Neuwirth CKY, Taylor GW, Thompson GR Atorvatatin augments therapy of homozygous familial hypercholesterolemia by inhibiting upregulation of cholesterol synthesis after apheresis and bile acid sequestrants. Circulation. 94(Suppl I):1996;583.